Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|January 13, 2019
NMLPA: Uncovering Overlapping Communities in Attributed Networks via a Multi-Label Propagation ApproachBingyang Huang, Chaokun Wang, Binbin Wang
IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society|June 27, 2017
Learning the Personalized Intransitive Preferences of ImagesJun Chen, Chaokun Wang, Jianmin Wang, et al.
Technology in Cancer Research & Treatment|September 29, 2020
Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and ReviewChaokun Wang, Jing Chen, Xiangyun Xu, et al.
Current Issues in Molecular Biology|December 22, 2022
MicroRNA-10 Family Promotes the Epithelial-to-Mesenchymal Transition in Renal Fibrosis by the PTEN/Akt PathwayChaokun Wang, Yichen Shuai, Chuan Zhao, et al.
Chemosphere|February 11, 2024
Response of fine particulate matter and ozone concentrations to meteorology and anthropogenic precursors over the "2+26" cities of northern ChinaPengfei Liu, Junwu Dong, Hongquan Song, et al.
The Science of the Total Environment|August 21, 2024
Cumulative effects of fish disturbance and vegetative propagules reduce the growth advantage of Vallisneria natansChaokun Wang, Qingyang Rao, Jianfeng Chen, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Anti-HER2×CCR4 bispecific antibody enhances antitumor immunity in advanced HER2-positive tumors by chemotaxis blockade and depletion of tumor-associated Tregs, without inducing systemic toxicityChaokun Wang, Jiachang Li, Yue Tong, et al.
Nature Communications|November 27, 2025
Molecular Motif Learning as a pretraining objective for molecular property predictionZiyang Liu, Chaokun Wang, Shuwen Zheng, et al.
Frontiers in Oncology|June 7, 2021
The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast CancerChaokun Wang, Shuzhen Deng, Jing Chen, et al.
Frontiers in Oncology|April 2, 2025
Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancerChaokun Wang, Shuzhen Deng, Jing Chen, et al.
Pageof 2